SUMMARY Between June 1978 and January 1982, 115 patients underwent 122 subclavian arterypulmonary artery shunts using polytetrafluoroethylene (PTFE Impra) grafts. Forty-six of the patients had a ductus dependent pulmonary circulation, the patency of which was maintained by an infusion of prostaglandin E2 in 29 cases. There were nine hospital deaths, four of which were related to shunt failure. Five patients underwent a second shunt procedure witiin one week of the first. There were two cases of late graft occlusion. Twelve shunts were considered to have failed. The actuarial estimate of shunt patency was 90% (± 3%) at two years for all patients and 74% (± 10%) for neonates. There was no statistically significant difference in two year shunt patency between 4 mm grafts (88 5%) and 6 mm grafts (96 3%).
Despite the current trend towards-early total correction of congenital cardiac defects, this is unsuitable for some patients with cyanotic heart disease. Such patients require a systemic pulmonary shunt, increasing pulmonary blood flow, either as temporary palliation before definitive surgery, or occasionally as a more permanent feature in conditions which we consider "uncorrectable" at the present time.
The problems of existing shunt procedures are well known. 12 Following the recent report of the modified Blalock shunt3 we present the use of polytetrafluoroethylene (PTFE Impra) grafts for systemic pulmonary shunts in 115 patients with cyanotic congenital heart disease.
Patients and methods
During the period June 1978 to January 1982, 122 modified Blalock shunts were performed in 115 patients at the Brompton Hospital. The median age was 4 months (range 1 day to 28 years). Twenty-four neonates underwent operation in the first week of life and a further 18 between 1 week and 1 month. The median weight was 4*5 kg (range 2*1 to 55 kg). Sixtytwo (54%) of the patients were male.
Accepted for publication 18 December 1982 In all cases, the indication for surgery was hypoxaemia caused by partially or completely obstructed pulmonary blood flow. The underlying cardiac conditions are shown in Table 1 . The pulmonary circulation was dependent on a persistent ductus arteriosus in 46 patients. Ten patients had undergone previous shunt operations (eight Blalock-Taussig and two Waterston) between two and four years previously. These patients required a second shunt procedure for increasing cyanosis. Nine of the shunts were widely patent but one Blalock-Taussig shunt was narrowed at the pulmonary artery anastomosis. Three hospital deaths were related to excessive pulmonary blood flow after modified Blalock shunts (Table 2 ). In one patient (case 6) the ductus was ligated and in another (case 7) the shunt banded in an attempt to control pulmonary oedema. The third patient (case 4) died after banding of the shunt and correction of the double outlet right ventricle. A fourth patient developed excessive pulmonary blood flow and was successfully treated by banding of the shunt. Forty two (45%) of the 94 surviving patients were receiving diuretics for pulmonary oedema related to excessive pulmonary blood flow before corrective surgery.
LATE DEATHS
There were 12 late deaths in this series. With the exception of the two patients already described, all shunts were patent at necropsy. In one case, however, there was evidence of neointimal proliferation at the subclavian artery anastomosis (Fig. 1 (Table 3) . Two of these later died when both shunts were found to be occluded. Thus, 12 of the total 122 shunts were considered inadequate. There have been no reports of shunt occlusion after six months. The actuarial estimate of overall shunt patency is 900/o (+3%) at two years. Eleven shunt failures occurred in neonates. Thus an actuarial estimate of shunt patency is 74% (± 10%) at two years in this group (Fig. 2) . ence in shunt patency for the 4 mm and the 6 mm modified Blalock shunt was not significant (p=02). The shunts proved effective in the surviving patients with mean arterial Po2 significantly raised from 4.6 (+1.7) kPa to 7*6 (+2-9) kPa (p<0-01). 79 (99) arteriosus in the neonates has obviated the need for 6 0 100 ) emergency shunt procedures.'2-14 Indeed, all operations described in this series were performed as urgent elective cases. ible 4 shows the incidence of shunt occlusion in Clearly, the pulmonary vascular resistance and in ion to the size of the shunt. The actuarial two particular the presence of distal stenoses are imporpatency rates based on graft size were 88% (+ tant causes of early shunt failure. Technical problems for 4 mm grafts, 790/o (+9%) for 5 mm grafts, are liable to be more crucial with the smaller grafts, 96% (±3%) for 6 mm grafts (Fig. 3) . The differ-though we feel that these have been largely overcome Table   Shunt (mm) 4 5 6 8 Ta relati year 5%) and ' with the application of microvascular surgical techniques. Indeed, there was no significant difference in shunt patency between the 4 mm grafts and 6 mm grafts at two years.
The high patency rate is a striking feature of this series and may be related to the routine use of antiplatelet therapyl' for three months, inhibiting platelet deposition and excessive neointimal proliferation at the anastomoses (Fig. 1) . In addition, after a bilateral shunt occlusion together with inferior vena caval and iliac artery thromboses in a patient with a persistently raised haematocrit,we have adopted a policy of venesection and plasma replacement at the time of surgery to maintain the haematocrit below 45%.
Forty two (45%) surviving patients required diuretics. In addition, four patients had such excessive blood flow to the lungs after the modified Blalock shunt that they required further surgery. This occurred irrespective of the size of the graft, indicating that while the subclavian artery regulates pulmonary blood flow in the majority of cases this is not universal.
Finally, the long term fate of the modified Blalock shunt remains in doubt. Fig. 4 shows an angiogram of a 4 mm shunt four years after surgery showing no evidence of distortion at the pulmonary anastomosis. This may, however, become a problem as the child grows, resulting in a further reduction in blood flow through the shunt which is no longer limited by the diameter of the subclavian artery but by that of the shunt itself.
Conclusions
The modified Blalock shunt using a polytetrafluoroethylene graft is an effective pulmonarysystemic shunt with a good short term patency. In general, the largest graft that can be tailored to the anatomy should be used. Antiplatelet therapy with dipyridamole and aspirin for three months after operation may increase graft patency. Ligation of the shunt is simply achieved with a single "Ligaclip". The long term fate of the modified Blalock shunt is unknown. Thus, we only recommend its use in those patients who are likely to undergo corrective surgery at a later date. 
